To investigate whether iron is involved in the reperfusion syndrome by aggravating free radical injury, the hearts from iron-loaded and control rats were perfused under normoxic, anoxic, and reperfusion conditions. Normoxic perfusion revealed no change in coronary flow, contractility, or lactate dehydrogenase (LDH) release between these two groups. Under anoxic and reperfusion conditions, however, we found a significant increase of ventricle fibrillation (56% vs. 0%, p<O.0l, n = 9), a significantly lower recovery of contractility (21 ± 7.4% vs. 81 ± 6.6%, mean ± SEM; p<0.001), and a significant increase of LDH release (667 ± 142 vs. 268 ± 37 mU LDH/min/g wet wt, mean ± SEM; p<0.05). Administration of either 20 /AM of the antioxidant (+ )-cyanidanol-3 or 50 ,uM of the iron-chelator deferoxamine totally prevented the generation of ventricle fibrillation and normalized contractility to control levels in the iron-loaded group. Moreover, 20 ,uM (+ )-cyanidanol-3 significantly lowered LDH release in this period (312 ± 67 mU), whereas deferoxamine had no protective effect on this LDH release (1,494 ± 288 mU). Normal hearts appeared to be protected by 20 ,uM (+)-cyanidanol-3 as well. In this group (n = 6), a significantly higher recovery of contractility (97.1 ± 3.2% vs. 81 ± 6.6%, p<0.05) and a significantly lower release of LDH (110 ± 27 vs. 268 ± 37 mU, p<0.05) was found compared with the control group (n = 9). No difference in superoxide dismutase or glutathione peroxidase activity was found between the groups. It is concluded that 1) iron-loaded rat hearts are more susceptible to anoxia and oxygen reperfusion damage; 2) iron load itself, under normoxic conditions, does not seem to be harmful; and 3) the antioxidant (+)-cyanidanol-3 is able to protect normal as well as iron-loaded rat hearts against anoxic and reperfusion damage. We suggest that iron plays an important role in the occurrence of tissue damage and ventricle fibrillation during anoxia and reperfusion, probably through the formation of hydroxyl radicals and/or perferryl oxide. (Circulation 1988;78:442-449) 
,uM of the iron-chelator deferoxamine totally prevented the generation of ventricle fibrillation and normalized contractility to control levels in the iron-loaded group. Moreover, 20 ,uM (+ )-cyanidanol-3 significantly lowered LDH release in this period (312 ± 67 mU), whereas deferoxamine had no protective effect on this LDH release (1,494 ± 288 mU).
Normal hearts appeared to be protected by 20 ,uM (+)-cyanidanol-3 as well. In this group (n = 6), a significantly higher recovery of contractility (97. Fisons, Leusden, The Netherlands) in the animals' gluteus muscles once a week for a period of 6 weeks and by adding a supplement (FeSO4 * 7H20; 7.5 ,ug Fe2+/g standard food) to their food during this period. The injections were administered after a brief anesthesia with diethylether. The control group was injected with dextran (10% solution) under the same conditions. No differences in body weight or behavior between the two groups during this period were observed. The perfusion experiments were performed 1 week after the last injection, at which time their body weight was 200-250 g.
Perfusion Protocol
The hearts were perfused according to Langendorff after using diethylether again as an anesthetic.
The perfusion was carried out at 370 C, pH 7.4. We used a modified Tyrode's buffer containing (mM) NaCI 128, KCI 4.7, CaCl2 1.3, NaHCO3 0.2, NaH2PO4 0.4, MgCl2 1, and glucose 11 saturated with 95% 02-5% CO2. Perfusion pressure was held constant at 80 cm H20. Coronary flow was measured indirectly in the aorta as a retrograde aortic flow (transflow 601 system, Skalar, Delft, Holland). During the initial equilibration period no differences were measured in contractility (Figure 1 ), flow (Figure 2 ), or LDH release (Figure 3 ) between the iron-loaded (n = 9) and control group (n = 9). In the iron-loaded group, six rat hearts developed ventricle fibrillation (VF) during anoxia or reperfusion (56%), whereas no VF was found in the control hearts (p<0.01, Fisher's exact test). Administration of ( + )-cyanidanol-3 (20 ,uM, n = 3) to the perfusion fluid completely protected the iron-loaded rat hearts during anoxia and reperfusion. We found no VF, whereas 56% was found in the unprotected iron-loaded group. In the reperfusion period, contractility was restored to control levels (87.7 ± 9.0%) and significantly different from the unprotected iron-loaded hearts (21 ± 7.4%, mean +±SEM; p<0.001, Figure 4 ). Perfusion with (+ )-cyanidanol-3 showed a complete normalization of LDH release to control levels (312.3 117.0 vs. 268 ± 37 mU), which is also significantly lower compared with the unprotected iron-loaded group (667 142, Figure 6 ). Coronary flow in the ironloaded hearts in the presence of cyanidanol revealed a pattern comparable with control hearts (Figures 2  and 5 ).
Administration of deferoxamine (50 jtM, n =3) protected the iron-loaded hearts against VF. Also, no VF was found in this group compared with 56% in the unprotected iron-loaded group. During reperfusion, contractility was restored to 68.0 ± 6.1% (Figure 4 ). Although this recovery was not as high as in the cyanidanol (87.7%) or control group (8 1%), it was significantly higher than in the unprotected iron-loaded group (p<0.01, Figure 4 ). Measurements of coronary flow, which are exhibited in Figure 5 , during anoxia with deferoxamine show no drop in coronary flow, which was seen with iron load alone. In the presence of deferoxamine, a higher LDH release was found during early reperfusion (Figure 6 ), after 10 minutes of reperfusion, however, LDH release became lower compared with the iron-loaded group although still higher than The protective effects of deferoxamine on reperfusion injury in normal heart tissue have been reported extensively in the literature.'8,'9 As far as we know, no reports have been presented on the effects of (+)-cyanidanol-3 on normal heart tissue during anoxia and reperfusion. We, therefore, studied these effects more extensively. The antioxidant (+)-cyanidanol-3 (20 ,uM) protected normal rat hearts under the same conditions against anoxic and reperfusion injury. During anoxia, contractility was the same in the ( +)-cyanidanol-3-protected (n = 6) and control groups (n = 9) (Figure 1 ). After 15 minutes of reperfusion, however, a significantly higher recovery of contractility with 20 ,uM (+)-cyanidanol-3 was found (97 + 3.2% vs. 81 + 6%, Figure 1 ). During early reperfusion, contractility recovered more rapidly and with less rhythmic disturbances in the (+)-cyanidanol-3 group. Also, LDH release during reperfusion was significantly lower in the (+ )-cyanidanol-3-protected group (110±27 vs. 268±37 mU, p<0.05; Figure 3 ), whereas coronary flow was significantly higher during early reperfusion (Figure 2 ). This might be related to contractility, which is restored earlier and with less rhythmic disturbances in these hearts.
Measurements of Total Iron and
Activities of Superoxide Dismutase and Glutathione Peroxidase Table 1 clearly reveals that administration of iron to the rats results in an increment of total iron content in the heart tissue. To exclude the possibility that the mechanism of anoxic and reperfusion injury is due to an impaired defense system against free radicals, SOD and glutathione peroxidase activities were measured. 25 Our experiments show that iron load itself, over a 6-week period, is not toxic. We found no differences in body weight or behavior between iron-loaded and control animals; moreover, under normoxic perfusion conditions, contractility, flow, and LDH release were the same in both groups. During anoxia and reperfusion, however, iron-loaded rat hearts turned out to be much more vulnerable, measured by a significant increase of VF, lower recovery of contractility, and higher release of LDH. The ironloaded rat hearts were protected with the antioxidant ( +)-cyanidanol-3 and the iron chelator deferoxamine, although LDH release with deferoxamine was higher compared with control levels and in contrast with protecting effects on VF and contractility. Because of equal SOD and glutathione peroxidase activities in both groups, it can be concluded that the occurring damage is not due to an impaired defense mechanism against free radicals but probably to a larger supply of OH radicals formed in the presence of increased iron amounts. During anoxia, mainly contractility is disturbed as shown by a significant increase of VF, whereas during reperfusion cell necrosis becomes more prominent as shown by a higher LDH release and lower recovery of contractility. Protection of normal as well as iron-loaded rat hearts during anoxia and reperfusion by (+)-cyanidanol-3 has never been reported before and might be a promising progress in establishing protective measures in ischemia. Although we cannot exclude that the long-term storage of iron damages the cell directly, it is shown by our data that iron-loaded rat hearts are much more susceptible during anoxia and reperfusion. This gives strong evidence that besides the generation of free radicals, the availability of transition metals, such as iron, are indispensible for mediating anoxic or ischemic damage. The use of iron chelators, which cannot induce lipid peroxidation,26 might therefore be a promising approach in preventing ischemic myocardial injury.
